^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

AB-205

i
Other names: AB-205, E-CEL UVEC
Associations
Trials
Company:
Angiocrine
Drug class:
Cell replacement
Associations
Trials
11d
E-CEL UVEC Cell Injection Treatment of Perianal Fistulas (clinicaltrials.gov)
P2, N=78, Not yet recruiting, Angiocrine Bioscience
New P2 trial
|
AB-205
1m
E-CEL UVEC Treatment for Anal Fissures (clinicaltrials.gov)
P1, N=20, Recruiting, Weill Medical College of Cornell University | N=12 --> 20
Enrollment change
|
AB-205
6ms
E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults (clinicaltrials.gov)
P1, N=20, Enrolling by invitation, Hospital for Special Surgery, New York | Trial completion date: Oct 2025 --> Oct 2026 | Trial primary completion date: Oct 2025 --> Oct 2026
Trial completion date • Trial primary completion date
|
AB-205
6ms
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas (clinicaltrials.gov)
P1, N=39, Recruiting, Weill Medical College of Cornell University | Trial primary completion date: Sep 2025 --> Sep 2026
Trial primary completion date
|
AB-205
10ms
E-CEL UVEC Treatment for Anal Fissures (clinicaltrials.gov)
P1, N=12, Recruiting, Weill Medical College of Cornell University | Trial completion date: Jun 2025 --> Dec 2026 | Trial primary completion date: Jun 2025 --> Dec 2026
Trial completion date • Trial primary completion date
|
AB-205
over1year
Trial completion date
|
AB-205
over1year
E-CEL UVEC Cells As an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults (clinicaltrials.gov)
P1, N=20, Enrolling by invitation, Hospital for Special Surgery, New York | Active, not recruiting --> Enrolling by invitation | Trial completion date: Oct 2024 --> Oct 2025 | Trial primary completion date: Oct 2024 --> Oct 2025
Enrollment open • Trial completion date • Trial primary completion date
|
AB-205
almost2years
E-CEL UVEC Treatment for Anal Fissures (clinicaltrials.gov)
P1, N=12, Recruiting, Weill Medical College of Cornell University | Not yet recruiting --> Recruiting
Enrollment open
|
AB-205
almost2years
E-CEL UVEC Treatment for Anal Fissures (clinicaltrials.gov)
P1, N=12, Not yet recruiting, Weill Medical College of Cornell University
New P1 trial
|
AB-205
almost2years
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas (clinicaltrials.gov)
P1, N=33, Recruiting, Weill Medical College of Cornell University | Phase classification: P1b --> P1 | N=12 --> 33 | Trial completion date: Dec 2031 --> Jun 2032 | Trial primary completion date: Dec 2024 --> Sep 2025
Phase classification • Enrollment change • Trial completion date • Trial primary completion date
|
AB-205
over2years
E-CELERATE: A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (clinicaltrials.gov)
P3, N=130, Terminated, Angiocrine Bioscience | Trial completion date: Dec 2025 --> Jan 2024 | Recruiting --> Terminated | Trial primary completion date: Jun 2025 --> Dec 2023; Interim analysis showed lack of efficacy
Trial completion date • Trial termination • Trial primary completion date
|
AB-205
over2years
Trial completion date • Trial primary completion date
|
AB-205